Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: A phase II dose-ranging randomised controlled trial ![]() ![]() ![]() |
Wallace Daniel J. , Strand Vibeke , Merrill Joan T. , Popa Serghei ![]() |
Annals of the Rheumatic Diseases |
Nr. / 2017 / ISSN - / ISSNe 0003-4967 |
Disponibil online 10 June, 2022. Descarcări-0. Vizualizări-291 |